Tag Archives: Germany’s

With new CEO on board, Germany’s Vibalogics lays out $150M for Boston viral vector site

With the race for COVID-19 vaccines heating up and the cell and gene therapy market booming, contract manufacturers in the viral vector space are quickly bulking up to meet demand. Hoping to ride that wave, Germany’s Vibalogics is planting its flag in the U.S. with a new leader in place.  Months after appointing a new… Read More »

Germany’s CureVac to launch human trial of experimental coronavirus vaccine – regulator

FRANKFURT (Reuters) – Unlisted German biotech firm CureVac will become the second company to launch human trials of an experimental coronavirus vaccine in the country, Germany’s vaccines regulator said on Wednesday. Reuters reported on Tuesday that the watchdog, the Paul Ehrlich Institut, would approve testing on humans of the experimental vaccine. [L8N2DT5XC] Reporting by Ludwig… Read More »